CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells

Gynecologic Oncology

Volumn 83, Issue 2, 2001, Pages 227-234

  Wobus, Manja ^a,b   Kuns, Robin ^a   Wolf, Claudia ^b   Horn, Lars Christian ^b   Köhler, Uwe ^b   Sheyn, Irena ^a   Werness, Bruce A ^a   Sherman, Larry S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

CD44; Cervical carcinoma; erbB2

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HERMES ANTIGEN; OLIGONUCLEOTIDE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; METASTASIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UTERINE CERVIX CARCINOMA;

EID: 0034763605     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6369     Document Type: Article

References (56)

1. Global cancer statistics
2. Report on consensus conference on cervical cancer screening and management
3. CD44: Structure, function, and association with the malignant process
4. The CD44 proteins in embryonic development and in cancer
5. CD44 is a marker of endocervical neoplasia
6. CD44 is an independent prognostic factor in early-stage cervical cancer
7. Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis
8. Splice variants of CD44 in human cervical cancer stage IB to IIB
9. CD44 splice variants as prognostic factors in invasive cervix carcinoma
10. CD44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma - An immunocytochemical study of 94 cases
11. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium
12. Expression of CD44 in uterine cervical squamous neoplasia: A predictor of microinvasion?
13. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours
14. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma
15. CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer
16. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium
17. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met
18. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth
19. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon
20. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor
21. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta
22. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons
23. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation
24. CD44 enhances neuregulin signaling by Schwann cells
25. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors
26. Oncogene alterations in carcinomas of the uterine cervix: Overexpression of the epidermal growth factor receptor is associated with poor prognosis
27. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix
28. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells
29. Expression of epidermal growth factor receptor in carcinoma of the cervix
30. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma
31. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina
32. The significance of Erb-b2 immunostaining in cervical cancer
33. Correlation of cervical carcinoma c-erb B-2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma
34. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease
35. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix
36. Prognostic value of c-erbB-2 expression in uterine cervical carcinoma
37. Immunohistochemical investigation and Northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri
38. D44 mediates human glioma cell adhesion and invasion in vitro
39. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps
40. Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors
41. Epidermal growth factor induces CD44 gene expression through a novel regulatory element in mouse fibroblasts
42. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44
43. Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44
44. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
45. EGF receptor
46. Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells
47. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function
48. Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy
49. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
50. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin
51. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer
52. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas
53. Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease
54. CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene
55. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells